We conclude that inhibiting ATX activity from non-cancer cells in the breast tumor and the cross-talk involving LPA with breast cancer cells provides an effective strategy for reducing tumor growth and metastasis and for increasing the effectiveness of chemotherapy and radiotherapy. Here, ENPP2 is linked to breast cancer.